Managers

Thryve grabs $1.4 mln

Thryve, a provider of microbiotics and microbiome testing, has secured $1.4 million in funding. The investors included PivotNorth Capital, Unilever Ventures, Darling Ventures, Candela Paramount, Abstract Ventures and Joyance Partners.

Ansun BioPharma attracts $85 mln Series A

San Diego-based Ansun BioPharma, a developer of anti-viral biologic therapeutics to combat severe viral respiratory tract infections, has closed $85 million in Series A financing. Sinopharm Healthcare Fund and Lilly Asia Ventures led the round with participation from other investors that included Lyfe Capital, Yuanming Capital, Matrix Partners China, 3e Bioventures Capital, Oceanpine Capital, VI Ventures and Joincap Investment.

Celsius Therapeutics snags $65 mln Series A

Cambridge, Massachusetts-based Celsius Therapeutics, which translates single-cell genomic insights into precision therapeutics for autoimmune diseases and cancer, has raised $65 million in Series A financing. Third Rock Ventures led the round with participation from other investors that included GV, Heritage Provider Network, Casdin Capital and Alexandria Venture Investments.

Switch Ventures bolsters data-driven approach with new hire

NEA considering large portfolio secondary sale, reports says

New Enterprise Associates is reportedly moving to sell a large piece of its portfolio in an effort to return capital to its limited partners, according to a news report in The Wall Street Journal.

Venture Investors targeting $100 mln for healthcare fund

Venture Investors is raising a sixth healthcare venture fund targeted at $100 million, according to a regulatory filing. The firm is led by James Adox, David Arnstein, Scott Button, John Neis, and Paul Weiss, with offices in Madison, Wisconsin, and Ann Arbor, Michigan.

Arrowroot, with TA pedigree, deploys most of Fund III, looks to SaaS opportunity

OpenView wraps up Fund V with more than $296 mln

Boston-based OpenView, an expansion-stage investor which has backed Balihoo, ExactTarget and Mashery, among others, has closed its fifth fund with $296.75 million in commitments, according to a regulatory filing. The commitments came from 23 investors, the filing reports. The firm was initially seeking $250 million, as reported last year, which is the same size as its fourth fund in 2014.

Get your guide to emerging manager investors here!

Voyager targets $100 mln for fifth fund

Voyager Capital is seeking to raise $100 million for its fifth fund, according to an SEC filing. Based in Seattle and Portland, Oregon, Voyager is a venture firm that invests in software, cloud and big data applications in the Pacific Northwest.